Cell and Gene Outsourcing

  1. GLP And The Impact To Start Up Companies 4/18/2022

    Good Laboratory Practice is often used in laboratories and is necessary for specific investigations. What does it mean? And how can it help start-up companies? Watch this video to learn more.

  2. Viral Vector Manufacturing: Improve Efficiency With A Platform Approach 9/25/2023

    Learn more about the platform-based scalable suspension process for LVV production and how it is impacting CGTs advancing toward commercialization.

  3. Bio4C ProcessPad™ Product Overview 5/19/2020

    Introducing Bio4C ProcessPad™ Software, part of the BioContinuum™ Platform.

  4. Tailored CMC Solutions That Meet Needs Of Novel Molecular Biologic Formats

    Explore an integrated drug substance/drug product CMC strategy and technical case studies that provide insight into delivering product-specific solutions and enabling the acceleration of novel molecular formats.

  5. Cryopreservation Best Practices For Cell & Gene Therapy Source Material 2/26/2024

    Industry experts share their experiences, including why and how cellular source materials are cryopreserved and why experience across cell types and methods matters.

  6. Early Developability And Analytical Toolbox For The Production Of Multi-Chain Biotherapeutics

    In recent years, the number of biotherapeutic molecules requiring more complex assemblies has greatly increased. Typically, these multi-chain molecules are no longer compatible with platform approaches and require a more agile approach to early developability and method development.

  7. Combining An MVA Technology Platform With Innovative Analytical Methods 7/21/2023

    Learn how this process development platform for MVA impacts vaccine manufacturing and supports the drug life cycle from process and analytical development through trials and commercialization.

  8. Practical Applications For Controlled And Safe Nucleic Acid Delivery 7/21/2025

    Explore the science behind LNP formulation development, from ionizable lipids to scalable manufacturing through case studies, screening strategies, and flexible approaches for advancing next-generation therapeutics.

  9. Purity As A Priority: Optimizing Safety Measures For rAAV Therapies 2/11/2025

    Watch to learn how rAAV vectors in gene therapy are addressing manufacturing impurities, risks to patient safety, and analytical methods for detection while aiding sponsors in regulatory compliance.

  10. Smart Bioprocess Data Utilization For Advanced Analytics And Monitoring With Data Analytics Tools Purpose-Built For Bioprocessing

    We share our experience working with organizations as they adopt solutions for automated data acquisition, aggregation, visualizations, and statistical analysis.